MedPath

Propofol Versus Sevoflurane During FESS

Phase 4
Conditions
Sinus Infection Chronic
Interventions
Registration Number
NCT04619160
Lead Sponsor
Algemeen Ziekenhuis Maria Middelares
Brief Summary

Good surgical conditions are crucial for an optimal surgery result and safe procedure. Minimal blood loss in the surgical field is one of the most important conditions to maintain a good visualization, especially in surgeries with a small surgical field such as a FESS (functional endoscopic sinus surgery). The perioperative blood loss is determined by the main arterial and venous pressure, the local pressure and the capillary vascular filling pressure.

It has been proposed that propofol is a venodilator, which increases the blood flow, but decreases the capillary pressure. On the contrary, sevoflurane might act mainly on the arterioles, which causes an increase in the capillary pressure. In a previous study it has been demonstrated that despite blood pressure maintenance, propofol causes less bleeding during spinal surgery than sevoflurane.

The main aim of this study was to compare both anaesthetics on the perioperative bleeding and haemodynamics during FESS. Secondary, the postoperative nausea, vomiting, pain scores, surgery duration and length of stay at the post-anesthesia care unit will be evaluated.

Detailed Description

2 X 30 patients which are planned for FESS surgery are randomized in a sevoflurane group or propofol group.

All patients will be induced with propofol (target-controlled infusion (TCI) 4 µg/mL) and remifentanil (TCI 4 ng/mL) and receive a multimodal intravenous analgesia.

Patients in the propofol group will receive further intravenous propofol until a bispectral index (BIS) value of 50 is reached.

The intravenous drip of propofol will be stopped after induction in the sevoflurane group and patients will receive sevoflurane as inhalation anaesthetic (1 MAC) until a BIS-value of 50. The surgeon will be blinded for patient allocation.

The surgical conditions will be graded postoperatively by the surgeon who performed the operation using the validated Boezaart grading scale. The endoscopic images will be evaluated in addition by 3 blinded surgeons using this same scale.

Besides the surgical conditions, haemodynamic parameters, nausea and vomiting scores (PONV), Visual Analogue Score (VAS), surgery duration, length of stay at the post-anesthesia care unit and postoperative analgesia and anti-emetics are registered.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patient planned for FESS surgery
Exclusion Criteria
  • patients which receive anticoagulants
  • patients which have coagulation disorders
  • patients with high bleeding risk
  • patients with arterial hypertension
  • other decided by surgeon

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
propofolPropofol-
sevofluraneSevoflurane-
Primary Outcome Measures
NameTimeMethod
Boezaart surgical grading scaleduring surgery

Evaluation of surgical conditions by determination of the validated Boezaart surgical grading scale. Score 0 (no bleeding) to 5 (severe bleeding) The scale will be determined by the operating surgeon and 3 independent surgeons based on an endoscopic video recording.

Secondary Outcome Measures
NameTimeMethod
Surgery durationImmediately after surgery

Length of surgery in minutes

Postoperative pain scoresin the first 48 hours after surgery

Postoperative Visual Analogue scores

Arterial blood pressureDuring surgery

Mean Arterial Blood Pressure (in mmHg)

Length of stay on the PACUFrom arrival on the PACU until achievement of the PACU discharge criteria

number of minutes on the PACU

PONV scoresIn the first 48 hours after surgery

Postoperative nausea/vomiting scores

Trial Locations

Locations (1)

General Hospital Maria Middelares

🇧🇪

Ghent, Oost-Vlaanderen, Belgium

© Copyright 2025. All Rights Reserved by MedPath